Cernilton and BPH

A selection of studies performed in patients with BPH using Cernilton
Author Year Study Titel / Study Design No of patients
Becker et al 1988 Conservative treatment of benign prostatic hyperplasia (BPH) with
Cernilton N - Results of a placebo-controlled double-blind study.
Buck et al 1990 Treatment of outflow tract obstruction due to benign prostatic hyperplasia with
the pollen extract, Cernilton. A double-blind, placebo-controlled study.
Maekawa et al 1990 Clinical eveluation of Cernilton on benign prostatic hypertrophy
– A multi center double-blind study with Paraprost
Braun et al 1993 Double-blind multi-center placebo-controlled study of efficacy and tolerability
of Adenoprostal1 in patients with benign prostatic hyperplasia (BPH)
1) Triple-strength Cernitol
Dutkiewicz 1996 Usefulness of Cernilton in the treatment of benign prostatic hyperplasia.
Comparative study vs Tadenan (Pygenum Africanum)
Aoki et al 2002 Clinical evaluation of the effect of tamsulosin hydrochloride and Cernitin pollen extract on
urinary disturbance associated with benign prostatic hyperplasia in a multicentered study
Cernilton: 73
Tamsulosin: 67
Combination: 72

Cernilton is a registered trademark of AB Cernelle
AB CERNELLE • HÖGANÄSVÄGEN 365 • SE-262 94 ÄNGELHOLM • SWEDEN • TEL +46 (0)42 69 230 • This email address is being protected from spambots. You need JavaScript enabled to view it.WWW.CERNELLE.COMSITEMAP